GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tsubota Laboratory Inc (TSE:4890) » Definitions » Common Stock

Tsubota Laboratory (TSE:4890) Common Stock : 円818.1 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tsubota Laboratory Common Stock?

Tsubota Laboratory's quarterly common stock increased from Jun. 2023 (円791.9 Mil) to Sep. 2023 (円815.6 Mil) and increased from Sep. 2023 (円815.6 Mil) to Dec. 2023 (円818.1 Mil).

Tsubota Laboratory's annual common stock increased from Mar. 2022 (円231.1 Mil) to Mar. 2023 (円789.0 Mil) and increased from Mar. 2023 (円789.0 Mil) to Mar. 2024 (円818.1 Mil).


Tsubota Laboratory Common Stock Historical Data

The historical data trend for Tsubota Laboratory's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsubota Laboratory Common Stock Chart

Tsubota Laboratory Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Common Stock
201.55 231.05 231.05 788.97 818.06

Tsubota Laboratory Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 788.97 791.92 815.56 818.06 818.06

Tsubota Laboratory Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Tsubota Laboratory (TSE:4890) Business Description

Traded in Other Exchanges
N/A
Address
34 Shinanomachi, 304 Toshin Shinanomachi-ekimae Building, Shinjuku-ku, Tokyo, JPN, 160-0016
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.

Tsubota Laboratory (TSE:4890) Headlines

No Headlines